Opening Hours : Saturday to Saturday - 9am to 6pm | Email: info@cancercarespecialtiesmena.com

13 Jan 2006
0

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. BMC Clin Pathol

Khoury T,  Tan D, Wang J, Intengan M, Yang J, Alrawi SJ, Yan P, Byrd JC. Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma.  BMC Clin Pathol. 2006 Jan 12;6(1):1.   Breast Surgery Dubai UAE Sadir Alrawi MD FRCSEd FRCSEng, Best Oncology Team for ColoRectal

Latest News

Seminar & Events

Archive